Article and Video CATEGORIES

Cancer Journey

Search By

CO-1686, a Third Generation Drug for EGFR Positive Lung Cancer Patients
Author
GRACE Videos and Articles

Dr. Heather Wakelee of Stanford University Medical Center talks about a drug still in development for EGFR lung cancer patients, CO-1686. February 2014.

[powerpress]

Next Previous link

Previous PostNext Post